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Introduction
Carcinoma rectum is the most common site of
gastrointestinal tract malignancy.1 Rectal cancer is
generally considered a disease of old age and up to 90 per
cent of patients are aged 55 years or above with an
average age of 65 years at the time of diagnosis.1 However,
recently there has been an increasing number of younger
patients, aged 40 years or less, diagnosed with rectal
cancer with variable reported incidence from different
population-based studies.2-4 O'Connell et al. have
evaluated the incidence and characteristics of colorectal
tumour from the nationwide Surveillance, Epidemiology
and End Results (SEER) cancer registry and, according to
them, the age-specific rates of colorectal cancer (CRC)
ranges from 0.8 to 7.8% in patients aged 20 to 40 years.5
This increase in incidence has been observed in the last 25
years with the annual increment of 2.6% in rectal
carcinoma vs. 0.2% in colonic carcinoma.5 It is thought that
rectal cancer in younger age group is associated with more
aggressive behaviour and advanced stage at diagnosis
compared to the older age group, but there are conflicting
views about the characteristics and prognosis of this
disease in young patients. Several retrospective studies
done to discover the clinicopathological characteristics of
colorectal cancer in young patients aged less than 40
years, lay emphasis on complete colorectal examination
regardless of age if symptoms are suggestive of colorectal
disease.5,6 Till date, very limited data discussing rectal
tumour in young patients is available from western
countries and none is available from Pakistan to address
rectal carcinoma in young patients.
The purpose of this study was to evaluate epidemiological
characteristics; clinical and pathological features; and
seven-year post-treatment follow-up of patients aged 40
years or below with rectal cancer in our region.
Patients and Methods
The retrospective case series comprised all patients with
biopsy-proven carcinoma rectum, aged below 40 years
from 1994 to 2004 at the Surgical Department of Aga
Khan University Hospital (AKUH), Karachi, Pakistan, with
complete 7-year followup. Patients with stage IV disease
at the time of diagnosis, those with incomplete medical
records, or followup less than 7 years or had partial
treatment outside were excluded.
Medical records of all patients who met the inclusion
criteria were reviewed. Data was collected on pre-
designed proforma based on literature search.
Information gathered about baseline variables, including
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Objectives: To determine epidemiological characteristics, clinical presentation, histopathological features, and
long-term follow-up of patients below 40 years of age with carcinoma rectum.
Methods: The retrospective case series comprised all patients presenting with histopathological diagnosis of
carcinoma rectum with age 15-40 years at the Aga Khan University Hospital between January 1994 and December
2004. Details regarding patient demographics, pre-operative assessment, management and tumour grade and
stage were obtained from a prospectively maintained database. Continuous and categorical variables in the data
were analysed.
Results: Of the 23 patients in the study, 14 (60.89%) were male and 9 (39.13%) were female. Mean age of the
subjects was 31±5 years. Overall, 22 (95.6%) patients presented with rectal bleeding and 12 (52%) had altered bowel
habit. The most common site for the tumour was lower rectum (n=20; 87%) and 13 (56.5%) required
abdominoperineal resection. Local recurrence rate was 13% (n=3) and distant metastasis occurred in 2 (8.6%)
patients during the seven year follow-up. Two (8.6%) patients died, and both had distant metastasis.
Conclusion: Carcinoma rectum is uncommon but an important malignancy in patients aged below 40 years. The
clinician should have a high index of suspicion in young patients presenting with bleeding per rectum, altered
bowel habit and weight-loss. 
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demographics, social and family history,
carcinoembryonic antigen (CEA) values at presentation,
clinical and pathological staging. Details of operative
procedure and information on neoadjuvant and adjuvant
treatment were also included. Information on local
recurrence and systemic metastasis in seven-year
followup was also recorded, and so was 7-year survival
and mortality. Continuous variables like age and duration
of symptoms were expressed as means with standard
deviation, while categorical variables like gender,
symptoms, risk factors, diagnostic investigations, were
expressed as frequency and percentage.
Results
A total of 28 patients had carcinoma rectum with age <40
years, but 5 (17.85%) could not be further evaluated as
they were stage IV cases at the time of diagnosis. The
study population, as such, was 23 (82.14%). Patients'
characteristics were recorded separately (Table-1). The
mean age of the subjects was 31±5 years. Nine (39%) of
them were female and 14 (61%) were male. The most
common clinical presentation was bleeding per rectum
(n=22; 95.6%), followed by altered bowel habits (n=12;
52%). Mean duration of symptoms before diagnosis was
9.7±6 months (range: 4-24 months). Smoking was found
to be an associated factor as 6 (26%) patients were
smokers. Positive family history of colorectal tumour was
only present in 4 (17%) patients. Among the diagnostic
investigation, colonoscopy (n=20; 87%), computed
tomography (CT) scan abdomen and pelvis (n=14; 61%)
was the most commonly used modalities. Pre-operative
CEA level was raised in 21 (91%) patients. 
The tumour characteristics were also evaluated (Table-2).
The lower rectum was the commonest site for the tumour
(n=20, 87%) and 13 (56.5%) patients required
abdominoperineal resection (APR). Histologically, the
predominant tumour type was adenocarcinoma (n=18;
78%) and most of them were either moderately (n=16;
70%) or poorly (n=5; 21.7%) differentiated. In Tumour,
Nodes, Metastases (TNM) classification, patients either
had mascularis propria T2 (n=6; 26%) or adventitia T3
(n=17; 74%), involvement and all of them had lymph node
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Table-1: Patient characteristics.
Patient characteristics (N=23) Mean ±SD/No. (%)
Age (mean) 31±5(18-39)
Gender 
Male 14(60.8%)
Female 9 (39%)
Symptoms
Bleeding per rectum 22 (95.6%)
Altered bowel habits 12 (52%)
Weight loss 5 (21.7%)
Abdominal pain 5 (21.7%)
Abdominal mass 3 (13%)
Others 3 (13%)
Duration of symptoms (mean) 9.7±6 (4-24)
Risk factors
Smoking 6 (26%)
Positive family history of CRC 4 (17%)
Diagnostic investigation
Colonoscopy 20 (87%)
Computed Tomography scan 14 (61%)
Barium enema 3 (13%)
Ultrasound abdomen 9 (39%)
Raised pre-op CEA level 21 (91%)
Chemotherapy 
Neoadjuvant 2 (9%)
Adjuvant 20 (87%)
Both 1 (4.3%)
Postoperative complication 15 (65%) 
Adhesive obstruction 4 (17%)
Wound infection 4 (17%)
Parastomal hernia 3 (13%)
Faecal peritonitis 3 (13%)
Erectile dysfunction 1 (4.3%)
CRC: Colorectal cancer. CEA: Carcinoembryonic antigen.
Table-2: Tumour characteristics.
Patient characteristics (N=23) No. (%)
Location of tumour
Upper third 1 (4.3%)
Middle third 2 (8.6%)
Lower third 20 (86.9%)
Type of surgical procedure
Abdominoperineal resection 13 (56.5%)
Low anterior resection 1 (4.3%)
Ultra low anterior resection 9 (39.1%)
Histopathology
Adenocarcinoma 18 (78.2%)
Mucinous adenoa carcinoma 4 (17.3%)
Signet ring cell carcinoma 1 (4.3%)
Grade of tumour
Well differentiated 2 (8.9%)
Moderately differentiated 16 (70%)
Poorly differentiated 5 (21.7%)
Histopathological staging 
T2 6 (26%)
T3 17 (74%)
N1 15 (65.2%)
N2 3 (13%)
N3 5 (21.7%)
Lympho vascular invasion 2 (8.9%)
Perineural invasion 1 (4.3%)
Local recurrence 3 (13%)
Distant metastasis 2 (8.6%)
invasion, mostly N1 (n=15, 65.2%) disease.
Despite the younger age group, a significant number of
patients (n=15; 65%) developed post-operative
complications, the common being post-operative
adhesive bowel obstruction (n=4; 17%) and wound
infection (n=4; 17%).
Three (13%) patients developed local recurrence within a
year after ultra-low anterior resection (ULAR) and required
APR. These recurrences were picked up on follow-up CT
scans; two (8.9%) in 6 months and 1 (4.34%) in 9 months
follow-up. Two (8.9%) patients developed distance
metastasis; 1 (4.34%) in the left bronchus and other to the
liver. The left bronchus metastasis was identified on CT
chest four year after the initial surgery, while liver
metastasis was identified after two years on follow-up CT
scan. They were treated with systemic chemotherapy. On
seven-year follow-up of all patients, two (8.6%) expired
and both of these were identified with metastasis. The rest
of the patients remained disease-free and are under
surveillance.
Discussion
The common perception that rectal carcinoma is mainly
the disease of elderly population is not true anymore as
there has been an increasing number of young patients
diagnosed with carcinoma rectum in the past two
decades. According to SEER cancer registry, incidence of
colonic tumour in young patients remained static, while
incidence of rectal cancer has shown annual increment for
the last twenty five years.3,7 This increased incidence is
observed in both genders and all races.8 Despite this
increasing incidence of rectal cancer in young population,
little is known about rectal cancer in developing
countries, especially Pakistan.
Multiple etiological factors are thought to increase the
risk of colorectal cancer.9 Some investigators have
implicated lifestyle changes as the cause for increased
incidence of rectal cancer, while others think of genetic
factors. None of these authors have been able to find
independent factor for this rise in the incidence of rectal
cancer compared to colonic cancer.2,10,11 In the current
study, smoking was found to be an important risk factor
(n=6; 26%) while none of the patients had familial
adenomatous polyposis (FAP) or hereditary non-polyposis
colon cancer (HNPCC).
The common clinical presenting features of young
patients with carcinoma rectum are bleeding per rectum,
altered bowel habit, anaemia and weight-loss.12 In young
patients, these symptoms may not alert the physician to
suspect malignancy as these symptoms may be
attributed to the common clinical diagnosis of
haemorrhoids. Timely diagnosis of young patients with
carcinoma rectum is pivotal as it does affect outcomes in
these patients. Mean duration of symptoms before
diagnosis in our study was 9.7±6 months (range 4-24) as
compared to 7 to 9 months in previous studies with
patients aged less than 40 years with colorectal cancer.6
This delay in diagnosis may be attributed to similarity of
symptoms in benign and malignant colorectal disease
and low index of suspicion in this age group.
A study on clinicopathologic and molecular features of
early-onset colorectal carcinoma was done by in 200910
and found that young patients with rectal cancer had
increased lymphovascular and venous invasion and the
tumour had increased infiltrative growth pattern. In this
study, majority of patients had infiltrative growth pattern
while lymphovascular invasion was found only in 8.9% of
the patients.
Studies from Asia, Africa and western countries on tumour
(T), lymph node involvement (N), and histological grade
of young patients is found to be less favourable compared
to the older group.13,16 Although the current study did not
have a comparison group, it found better
histopathological features as most of the patients had
moderately differentiated (70%), adenocarcinoma (78%),
either T2 (26%) or T3 (74) lesion, and N1 involvement
(65%). 
Lower rectum was found to be the most common site for
tumour (86.9%); therefore most of the patients required
APR (56.5%) in our study. A series of 102 young patients
with rectal cancer from a tertiary care hospital in India also
found the lower rectum as the common site for tumour
and, as a result, patients were less likely to be candidates
for sphincter preservation surgery.12
In the current study, local recurrence rate was 13% and
distant metastasis was found in 8.6% of the patients in
seven-year post-treatment follow-up. To the best of our
knowledge, none of the published data on rectal cancer in
young patients has discussed local recurrence and
systemic metastasis in a seven-year follow-up time period.
The local recurrence developed in patients treated with
ULAR and they were treated with APR. Post-operative
complications were developed in 65% patients despite
being a young population, and common complications
were adhesive bowel obstruction and wound infection.
One explanation for this high complication rate is that
malignancy itself is an independent risk factor for post-
operative complications. This finding had not been
discussed in the available literature.
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This study had its own share of limitations. We did not
have a comparison group to quantify the clinical and
histopathological differences between the young and the
elderly patients. Besides, we did not have a proper
population cancer registry system, and, therefore, we do
not know the incidence of rectal cancer in the general
population. It was a retrospective study and had all the
limitations associated with such type of a study. Despite
these limitations, however, this study does provide a
roadmap for further reaserch.
Conclusion
Rectal cancer in young patients present with trivial
symptoms of bleeding per rectum and altered bowel
habits. The clinician should have a high index of suspicion
in young patients, especially if they are smokers and
report weight-loss. These patients warrant digital rectal
exam and proctosigmoidoscopy as most of the tumours
are within the reach of these examinations. We also
suggest having our national colorectal cancer registry
system for collecting and formulating the necessary data
and to know the incidence of colorectal cancer in the
general population.
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